Skip to main content

GenVault Licenses DNA Labeling Technology from the University of Texas

NEW YORK, May 11 (GenomeWeb News) - Genvault has exclusively licensed DNA labeling technology from the Universityof Texas, the San Diego-based company said today.


The patent licensed by GenVault, USPatent No. 6, 153,389, covers a technology for labeling biological samples like blood, semen, or saliva for subsequent DNA analysis. It provides a distinctive label for biosamples for future identification, according to GenVault.


The patent allows GenVault to offer and license GenCode, its own DNA labeling technology, to a broader market.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.